Staging of cervical cancer complicating pregnancy

Key points
- Palaia et al report a case of a patient with locally advanced cervical carcinoma without lymph node metastasis treated by neoadjuvant chemotherapy during pregnancy followed by cesarean section and radical surgery.
- Palaia I, Pernice M, Graziano M, Bellati F, Panici PB.
- The pretherapeutic tumoral staging of this patient by cervical biopsy and pelvic magnetic resonance imaging as locally advanced stage is insufficient to specify the prognosis and to guide the therapeutics.
- The lymph node staging could have been carried out by laparoscopic lymphadenectomy during the pregnancy.
Palaia et al report a case of a patient with locally advanced cervical carcinoma without lymph node metastasis treated by neoadjuvant chemotherapy during pregnancy followed by cesarean section and radical surgery.
The pretherapeutic tumoral staging of this patient by cervical biopsy and pelvic magnetic resonance imaging as locally advanced stage is insufficient to specify the prognosis and to guide the therapeutics. Indeed, there was no lymph node staging for this patient before the chemotherapy. However, the knowledge of the pelvic lymph node status is a major element of prognosis of cervical cancers.
The lymph node staging could have been carried out by laparoscopic lymphadenectomy during the pregnancy. Indeed, certain teams showed the safety and feasibility of the pelvic laparoscopic lymphadenectomy and its interest to guide therapy during pregnancy. Only surgical staging before treatment gives complete information about tumor extension and status of the pelvic/paraaortic lymph nodes. In the absence of lymph node involvement (as it is the case presented), a radiotherapy could have been proposed to the patient.
It has also been recently shown that radiotherapy during the second and third trimester of pregnancy is relatively harmless when patients are very keen to maintain their pregnancy. The chemotherapy could have been delayed after the fetal extraction and would have probably been better tolerated and thus more effective. Moreover, although trials of neoadjuvant chemotherapy seem promising, we do not have enough distance to conclude about its safety on the fetus in the medium and long term. It will be necessary to follow up this child during several years to conclude about the safety of the chemotherapy on her mental and physical state.
The absence of lymph node involvement would be rather a good prognosis; nevertheless, the lymph node staging after the chemotherapy is not satisfactory because chemotherapy might have sterilized lymph nodes that had been involved.
Finally, the follow-up of this patient is too short (only 10 months) to draw conclusions about the success of the treatment. It would be necessary to have news from this patient in a few years.
References
1. Palaia I, Pernice M, Graziano M, Bellati F, Panici PB. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. Am J Obstet Gynecol. 2007;197:e5–e6.
2. NCCN physician guidelines for cancer care. cervical cancer, practice guidelines in oncology-v.1.2007.
3. Hertel H. Laparoscopic lymph node staging of cervical cancer in the 19th week of pregnancy (A case report). Surg Endosc. 2001;15:324.
4. Stan C, Megevand E, Irion O, Wang C, Bruchim I, Petignat P. Cervical cancer in pregnant women: laparoscopic evaluation before delaying treatment. Eur J Gynaecol Oncol. 2005;26:649–650.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsSome types of papilloma virus might prevent cervical cancer
There are over 100 different types of human papilloma virus (HPV). Cervical cancer is known to be caused by infection with approximately 14 so-called “high-risk” types of this virus. Researchers from Manchester looked…
11 April 2013
NewsNew imaging agent enables better cancer detection, more accurate staging
Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping…
21 March 2013
NewsVaccine group funds cervical cancer immunizations for poor
The GAVI global vaccines group is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline. The…




